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Abstract 
Background: Combination doxycycline/macrocyclic lactone (ML) protocols have been shown to provide a more 
rapid adulticidal and microfilaricidal effect than either MLs or doxycycline alone, although female worms were 
reported to have a higher tolerance to treatments compared to male worms. The present study aimed to evaluate 
how ABC transporters may be involved in the synergic effect of the combination treatment. Adult worms of D. immitis 
were treated in vitro for 24 hours with doxycycline (DOXY), ivermectin (IVM) and a combination of both, and changes 
in the modulation of ABC transporter genes were measured. Levels of doxycycline inside different treatment media, 
post-treatment, were determined through HPLC analysis.
Results: Quantitative RT-PCR analysis showed the presence of changes in the modulation of ABC transporter genes 
evaluated in this study. In particular, in female worms, the combination treatment induced a substantial increase in 
gene expressions, especially of Dim-pgp-10 and Dim-haf-4; whereas in male worms, the greatest increase in gene 
expression was observed for Dim-pgp-10 and Dim-pgp-11 when treated with DMSO + IVM and DMSO + DOXY/IVM. 
HPLC analysis of the DOXY concentrations in the media after in vitro treatments of male worms showed a slight dif-
ference between the DMSO + DOXY samples and the combination (DMSO + DOXY + IVM), while no difference was 
observed among females.
Conclusions: Further studies are required to explain whether the modulation of cellular efflux plays a role, even 
partially, in the adulticide effect of doxycycline/macrocyclic lactone combinations in heartworm-infected dogs. To the 
authors’ knowledge, this is the first study to evaluate P-gp expression in adult D. immitis.
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Background
Dirofilaria immitis is a vector-borne parasite transmitted 
by different species of mosquitoes and the etiologic agent 
of canine heartworm disease. The disease is endemic in 
many parts of the world and is currently spreading to 
previously unaffected areas [1–6].
Melarsomine dihydrochloride (Immiticide®, Merial) is 
the only approved adulticidal drug for treatment of patent 
D. immitis infections. Protocols combining doxycycline, 
which targets the bacterial endosymbiont Wolbachia, 
together with a macrocyclic lactone, are currently recom-
mended either as pre-adulticide preparation (resulting in 
less severe post-melarsomine complications) [7, 8] or as 
an alternative to melarsomine when this is unavailable or 
contraindicated [6, 9].
Doxycycline has various detrimental effects on devel-
oping and adult heartworms, including degeneration 
of oocytes and early embryonic stages, but its adulti-
cide efficacy is low and slow [10]. Macrocyclic lactones 
(MLs) are highly efficacious against L3 and young fourth-
stage larvae (L4) and prevention of disease is based on 
this activity [11]. Long-term administration of preven-
tive doses of MLs have also been reported as having a 
so-called “slow kill” effect against adult D. immitis (for 
review see [12]). As with doxycycline, however, the adul-
ticide effect is slow (typically 24–36  months) [13]. Fur-
thermore, the use of macrocyclic lactones as adulticides 
has been implicated in the development of drug resist-
ance and is no longer recommended [11, 14].
The doxycycline/ML combination protocols that have 
been evaluated in experimentally and naturally-infected 
dogs have been shown to be highly effective in clearing 
infection in a relatively short time [7, 13, 15]. It is not cur-
rently known, however, why doxycycline/ML combina-
tions provide a more marked and rapid adulticidal effect 
than the two drugs alone. Furthermore, in a few studies 
which evaluated worm populations at necropsy follow-
ing different combination protocols, female worms were 
often found to survive drug treatment, suggesting a cer-
tain tolerance towards the adulticide effects of this treat-
ment protocol [7, 15, 16].
It is well known that ATP-transporters (ABCTs), 
including P-glycoproteins, are involved in the active 
carriage of drugs and other molecules and metabolites 
across cell membranes [17]. Their role in inducing drug 
resistance has also been widely demonstrated [18–21]. 
Recently, Mani et al. [22] reported that macrocyclic lac-
tones are able to modulate P-gp activity in D. immitis, 
with ivermectin being a potent inhibitor. Doxycycline has 
been shown to inhibit P-gp activity in mammals [23], but 
there is no available data regarding such interaction with 
D. immitis or other nematodes. The adulticide effect of 
the doxycycline/ML combinations may therefore be due 
to interaction with cellular efflux mechanisms. Indeed, if 
these drugs inhibit P-gp activity, thus allowing for accu-
mulation of higher concentrations within the nematode 
compared to treatment with either drug alone, eventual 
lethal effects may be enhanced.
To further explore the effect on cellular efflux, in the 
present study we determined the expression level of 
genes coding for P-gp transporters Dim-pgp-10, Dim-
pgp-11 and Cel-haf-4 in adults of D. immitis treated in 
vitro with doxycycline, ivermectin and a combination of 
both. We also evaluated doxycycline concentrations in 
the culture medium following treatment.
Methods
Reagents
All reagents were purchased from Sigma-Aldrich (St. 
Louis, MO, USA), except where indicated.
Collection and maintenance of D. immitis adults
Seven privately-owned dogs that had never received 
macrocyclic lactones or doxycycline were diagnosed 
with patent D. immitis infection. Following owners’ con-
sent, dogs underwent minimally-invasive surgical heart-
worm removal [9]. A total of 15 female and 15 male adult 
worms were collected during surgeries. Extracted worms 
were washed in HBSS medium at room temperature, 
checked for viability, counted, sexed, and then placed 
individually into 50 ml of RPMI medium and stored over-
night at 37 °C, 5%  CO2.
In vitro treatment of adults
Adult parasites were placed individually in tubes with 
50 ml of NI media [24]. They were then treated as follows: 
1% DMSO alone (DMSO), ivermectin (3.54 nM) with 1% 
DMSO (DMSO + ivermectin), 1% DMSO in combination 
with doxycycline (56.5  µM) (DMSO + doxycycline), and 
a combination of doxycycline (56.5 µM) and ivermectin 
(3.54  nM) together with 1% DMSO (DMSO + doxycy-
cline + ivermectin). Untreated samples, plain NI media, 
served as controls. Concentrations of the two drugs were 
chosen according to their highest plasma concentra-
tions measured after in vivo treatments of dogs [25, 26]. 
Given that the present in vitro study attempted to mir-
ror what occurs in vivo, drug concentrations were not 
calibrated based on the parasite’s gender and study media 
volumes were standardized to 50 ml for both sexes. Each 
treatment was performed in triplicates, for both sexes. 
Tubes were maintained for 24 h at 37 °C, 5%  CO2. Expo-
sure time was chosen based on a previous study on IVM 
treatments both in vivo as well as in vitro of other nema-
todes [27, 28]. Samples were checked for vitality and, 
after being washed in HBSS, they were promptly frozen 
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at − 80 °C. After the treatment, all media were stored at 
− 20 °C.
HPLC for doxycycline medium levels
The concentrations of doxycycline in different treat-
ment media (DMSO + doxycycline and DMSO + doxy-
cycline + ivermectin) post treatment were measured by 
means of HPLC method as described by Menozzi et  al. 
[29]. A standard curve was prepared with doxycycline in 
NI media. The internal control selected for the study was 
DMSO + doxycycline.
For this analysis a Prostar LC Workstation (Varian 
Co., Walnut Creek, CA, USA), with a Prostar325 UV-Vis 
detector and a 10 µl loop were used. While for the chro-
matographic separation a Syncronis C18 analytical col-
umn (Thermo, Milan, Italy) (5 µm particle size, 150 × 4.6 
mm) was selected. Acetonitrile and 0.01 mol/l trifluoro-
acetic acid (30:70, v/v) were used as mobile phase, with 
a flow rate of 1.0 ml/min and an analytical wavelength of 
350 nm. The software Star Chromatography Workstation 
System control v.0.41 by Varian was used.
RNA extraction
Each frozen worm was homogenized in TRIzol® rea-
gent (Ambion®, Foster City, CA, USA) individually with 
the help of an electric pellet pestle (Sigma-Aldrich®, 
Missouri, USA). After homogenization, due to their dif-
ferent starting size (~ 200 mg for females and ~ 100 mg 
for male), in order to perform the extraction under the 
best suitable conditions female samples were split into 
four 1.5  ml tubes and male samples were split into two 
1.5  ml tubes. Each tube was used for RNA extraction 
according to the manufacturer’s instructions of the TRI-
zol® reagent. The starting volume per each tube was set 
to 1 ml of TRIzol®. RNA samples were rehydrated into 
100 µl of DEPC  H2O. Concentrations and quality of RNA 
samples were measured through spectrophotometer 
analysis (BioSpectrometer® fluorescence with μCuvetta® 
G 1.0, Eppendorf, Hamburg, Germany). Genomic DNA 
traces were removed with TURBO™ DNase treatment 
(Thermo Fisher Scientific, Waltham, MA, USA). A sec-
ond RNA extraction step was performed, as described 
earlier, except for the volume of DEPC  H2O used for 
rehydration (35 µl), followed by a second analysis at the 
spectrophotometer. Three hundred nanograms of each 
final RNA sample was used to produce cDNA by an ini-
tial step of AccuRT genomic DNA removal (Abm, Rich-
mond, Canada), followed by second step of OneScript® 
cDNA Synthesis Kit (Abm). Resultant cDNAs were used 
as a template for molecular analysis.
Quantitative reverse‑transcription PCR (qRT‑PCR)
The sequences of two ABC-B transporters genes (Dim-
pgp-10, Dim-pgp-11) and of one ABC-B half transporter 
gene (Dim-haf-4) have been previously described [30]. 
Primers sets were tested in order to optimize the effi-
ciency and the dynamic range of the reaction. As endoge-
nous control, the 18S ribosomal subunit was selected [7]. 
All primers used for this study are listed in Table 1. Three 
biological replicates of both sexes were prepared per each 
treatment of interest. Three technical replicates were 
analyzed per each biological replicate. The gene expres-
sion study was carried out by means of a relative qRT-
PCR, where results were normalized, first to the internal 
control gene (18S rDNA) and then to the treatment con-
trol (NI alone). The BrightGreen 2× qPCR Mastermix 
(Abm) was used according to the manufacturer’s instruc-
tions. The amplification protocol was as follows: dena-
turation at 95 °C for 1 min 30 s, followed by 40 repeated 
cycles (95 °C for 15 s; 59.4 °C for 1 min for Dim-pgp-10 
and Dim-pgp-11 genes, while 57.7  °C for 1 min for the 
Dim-haf-4 gene; 72 °C for 20 s). The final concentration 
for each primer in all reactions was 0.35  µM. Fluores-
cence signals were collected at every cycle and to avoid 
the presence of unspecific products, a melting curve 
analysis was performed.
Table 1 Primers used in the present study to evaluate the expression of the two ABC-B transporter genes and the ABC-B half 
transporter gene
Abbreviations: F, forward; R, reverse
Gene Primer name Primer sequence (5′–3′)
Dim-pgp-10 DimmScaf48-cDNA-F8 F: GCC ATC GTA GGT CCA TCA GGT TCT GGT 
DimmScaf48-cDNA-R12 R: TGT TCA ACT GAA ACG ACC ACA CGT C
Dim-pgp-11 DimmScaf04-cDNA-F6 F: TTA ACA GTG TTG ATG AAG GAT CAA ATCC 
DimmScaf04-cDNA-R6 R: ATA TTT CGC TGC GGT CTT GTTGG 
Dim-haf-4 DimmScaf101-cDNA-F5 F: GTG CAA ACT CGA GGT TTT GCTGT 
DimmScaf101-cDNA-R2 R: TCC ACC TCG AAG ACC TCC AGCA 
18S rDNA 18SQ-F F: GGG ACA AGC GGT GTT TAG C
18SQ-R R: GCA CGC TGA TTC CTC CAG T
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Data analysis
Results were presented as the relative change in gene 
expression  (2−ΔΔCt) ± standard deviation (SD) of the 
three biological replicates. All Ct values were managed 
by CFX Manager software (Bio-Rad, Hercules, CA, USA) 
and  2−ΔΔCt was calculated according to the Livak method 
[31]. Results were normalized, first to the internal control 
gene (18S rDNA) and then to the treatment control (NI 
alone). Three biological samples were analyzed per sex. 
The standard deviation between each technical replicate 
was calculated. All standard deviations were lower than 
0.3, which is the threshold value for a Ct standard devia-
tion to be considered accurate, as described in the “Guide 
to performing relative quantitation of gene expression 
using real-time quantitative PCR” published by Thermo 
Fisher Scientific [32]. The standard deviation per each 
 2−ΔΔCt was calculated according to the same manual. 
Data normality and distribution were tested respectively 
with Pearson test and two-way ANOVA using GraphPad 
Prism v.8.0.1 (GraphPad Software, San Diego, CA, USA; 
http://www.graph pad.com) and P-values < 0.05 were con-
sidered significant.
Results
Determination of gene expression profile after treatment
Quantitative RT-PCR analysis of Dim-pgp-10, Dim-
pgp-11 and Dim-haf-4 gene expression showed very little 
variation between NI controls (whose values were set to 
1) and medium with DMSO alone (whose values ranged 
between 0.9-fold and 1.4-fold). Thus, results are reported 
for the other treatments compared to DMSO as solvent 
control.
Interestingly, different expression patterns were 
observed for female vs male worms exposed to the dif-
ferent drug protocols. In female worms (Fig.  1), P-gp 
gene expression was downregulated following treat-
ment with ivermectin (for all three genes, less than 1/4 
of the amount of target RNA as the control/calibra-
tor), and upregulated when treated with doxycycline, 
reaching a fold difference of approximately 4 for both 
Dim-pgp-10 and Dim-pgp-11. Combination treatment 
(doxycycline+ivermectin) caused a marked increase in 
gene expression in female worms, in particular for Dim-
pgp-10 and Dim-haf-4 (4.3-fold and 3.5-fold, respec-
tively). Expression of the ABC transporters in male 
worms showed a different pattern (Fig.  2). Exposure to 
ivermectin caused increase of gene expression (up to 
4.1-fold in Dim-haf-4), while treatment with doxycy-
cline showed almost no effect on any of the three genes 
analyzed, whose fold gene expression ranged between 
1.16–0.79 (Dim-pgp-11 and Dim-haf-4, respectively). 
When the two drugs were administered in combination, 
however, gene expression was upregulated, but to a lesser 
degree than that observed in female worms (maximum of 
1.9-fold observed for Dim-haf-4).
None of the differences in gene expression following 
the various treatment protocols were statistically signifi-
cant when compared to the negative controls (NI alone). 
The lowest P-value (0.053) was observed between the 
control and the combination treatment for Dim-haf-4 
gene expression in females. As reported by Amrhein 
et  al. [33], statistically non-significant results cannot be 
taken as proof of the null-hypothesis. Therefore, we can 
still consider the results collected in this study as reliable 
despite their statistical “non-significance”.
Determination of doxycycline concentrations in treatment 
media
HPLC analysis of the doxycycline concentrations in the 
media after in vitro treatments of worms with either 
doxycycline alone or ivermectin + doxycycline showed 
a slight difference between the two sexes (Fig. 3). Media 
from female worms contained a lower concentration of 
doxycycline in the media compared to male media for 
both treatment protocols. When comparing the two 
treatment media concentrations, the doxycycline sam-
ples had lower concentrations of doxycycline than media 
from all worms treated with the combination doxycy-
cline/ivermectin. None of the observed differences were 
statistically significant (P > 0.9).
Discussion
Several studies in experimentally- and naturally-infected 
dogs have reported a marked adulticidal effect of com-
bination treatment with doxycycline + macrocyclic lac-
tones against D. immitis. Bazzocchi et  al. [7] reported 
that this adulticidal effect was significantly higher than 
when either drug is used alone, suggesting a possible syn-
ergism between the two. In an attempt to shed light on 
the possible mechanisms responsible for this, we evalu-
ated cellular efflux gene expression and doxycycline con-
centrations in the media, following in vitro treatment of 
adult worms.
The most interesting result of the present study is the 
differential gene expression between male and female 
worms following treatment. In female worms treated with 
ivermectin, all three genes were downregulated, suggest-
ing an inhibitory activity of ivermectin on cellular efflux. 
In male worms, however, there was a 3.4-fold, 2.9-fold 
and 4.1-fold increase in Dim-pgp-10, Dim-pgp-11 and 
Dim-haf-4 expression, respectively, suggesting a stimula-
tory effect. Mani et al. [22] reported that both ivermectin 
and selamectin markedly inhibited cellular transport by 
Dim-pgp-11 expressed in mammalian cells. Upregulation 
of P-gp expression, on the other hand, has been reported 
as a possible mechanism of drug resistance against 
Page 5 of 9Lucchetti et al. Parasites Vectors          (2019) 12:401 
Fig. 1 Expression of Dim-pgp-10 (a), Dim-pgp-11 (b) and Dim-haf-4 (c) genes in adult females of D. immitis treated with the following: 1% DMSO 
alone (DMSO), 1% DMSO in combination with 3.54 nM IVM (DMSO+IVM), 1% DMSO in combination with 56.5 µM DOXY (DMSO+DOXY), 1% DMSO 
in combination with 3.54 nM IVM and 56.5 µM DOXY (DMSO+IVM+DOXY). Results are expressed as fold change of the gene of interest  (2−ΔΔCt), 
normalized first to the internal control (housekeeping gene: 18S) and then to the control treatment (plain NI media). Data are presented as the 
mean ± SD of the three technical replicates per each biological one
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Fig. 2 Expression of Dim-pgp-10 (a), Dim-pgp-11 (b) and Dim-haf-4 (c) genes in adult males of D. immitis treated with the following: 1% DMSO 
alone (DMSO), 1% DMSO in combination with 3.54 nM IVM (DMSO + IVM), 1% DMSO in combination with 56.5 µM DOXY (DMSO + DOXY), 1% 
DMSO in combination with 3.54 nM IVM and 56.5 µM DOXY (DMSO + DOXY + IVM). Results are expressed as fold change of the gene of interest 
 (2−ΔΔCt), normalized first to the internal control (housekeeping gene: 18S) and then to the control treatment (plain NI media). Data are presented as 
the mean ± SD of the three technical replicates per each biological one
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macrocyclic lactones in several nematodes, including H. 
contortus, C. elegans and equine cyathostomins [34–36]. 
In the present study, worms were isolated from naturally-
infected dogs that had not received preventive treatment 
with either doxycycline or macrocyclic lactones. Further-
more, infected dogs were from a geographical area where 
the first case of autochthonous infection was reported in 
2007 and where regular heartworm prevention is still not 
practiced routinely [37, 38], making the presence of drug 
resistant isolates highly unlikely. Therefore, the authors 
suggest that there is a sex-related modulation in P-gp 
expression in D. immitis following exposure to ivermec-
tin. Interestingly, similar results were reported in 2013 
where P-gp gene expression tended to be increased by 
ivermectin treatment in male Cooperia oncophora [39].
This differential expression of P-gp genes is also evident 
following exposure to doxycycline, causing upregulation 
in females and downregulation in males. This is particu-
larly interesting given that one of the principal differences 
between male and female D. immitis is the presence in 
females of a large number of Wolbachia, especially in the 
female reproductive system. It is reasonable to hypoth-
esize that female worms would respond to antibiotic 
treatment with defense mechanisms aimed at reducing 
drug concentrations in order to protect the endosymbi-
ont and, by doing so, protecting itself. Indeed, it has been 
shown that there exists an obligate dependency of these 
worms on Wolbachia for normal embryogenesis and 
viability [40, 41]. According to a gene expression study 
of Wolbachia from Onchocerca ochengi, ATP provision-
ing was identified as one of the primary contributions 
of the symbiont to the mutualistic relationship in filarial 
worms [42]. ABC transporters, including P-gps, are ATP-
dependent, and results from the present study would 
suggest that Wolbachia is contributing to cellular detoxi-
fication in D. immitis females exposed to doxycycline. 
Why this does not happen in male worms may be due to 
the location of P-gps. In a recent study, Godoy et al. [43] 
reported that HcoP-gp9 localized to the uterus of adult 
females. Wolbachia is present in the entire female repro-
ductive apparatus, while it is only present in the hypoder-
mal chords of males. There is, however, no information 
on the tissue distribution of D. immitis P-gps.
The results of the present study regarding gene expres-
sion following combination treatment with ivermec-
tin and doxycycline were similar in both males and 
females, with a more marked upregulation of all genes 
in females. As mentioned above, those studies which 
evaluated worm count at the end of combination proto-
cols in infected dogs consistently report at least one or 
two female worms as surviving, while the death of male 
worms is 100% [7, 15]. A more intense cellular detoxifi-
cation in females may explain this phenomenon. Results, 
however, do not explain why the two drugs together 
have a higher adulticide effect than the two drugs used 
separately. This is likely due to the short exposure time 
(24 hours) to the drugs and/or the low drug concentra-
tions used. Indeed, if these drugs activate P-gps in a dose-
dependent, saturable way, it is possible that expression 
will be modulated differently with longer exposure times 
and/or higher drug concentrations. The results from 
doxycycline concentration measurements in the culture 
media, while confirming a higher efflux/lower uptake of 
doxycycline in worms treated with the combination pro-
tocol, seem to contrast with the results of gene expres-
sion in females vs males, indicating a possible lack of 
correlation between gene expression and functionality. 
A potential summation effect induced by a higher uptake 
of doxycycline when administered in combination with 
ivermectin was evaluated by Menozzi et  al [29]. They 
found no statistically different concentration levels of 
doxycycline in plasma of dogs treated with doxycycline/
ivermectin compared to those treated with doxycycline 
alone. Another study evaluated whether the administra-
tion of doxycycline/ivermectin could be responsible for 
reversing the phenomenon of immunological tolerance 
towards the parasite [44]. The authors reported a signifi-
cantly lower number of T regulatory cells in the lungs of 
dogs treated with a combination of both drugs compared 
to dogs treated with doxycycline or ivermectin alone. It is 
likely that other variables are at work in eliminating the 
worms from the host environment. In this light, it must 
not be forgotten that doxycycline has numerous, non-
antibiotic effects in many cells/tissues. One of the most 
Fig. 3 HPLC analysis of doxycycline levels found in different 
treatment media after adult D. immitis treatment. Media analyzed 
were as follows: 1% DMSO in combination with 56.5 µM DOXY (DMSO 
+ DOXY), 1% DMSO in combination with 3.54 nM IVM and 56.5 µM 
DOXY (DMSO ± DOXY ± IVM). This histogram shows the average 
doxycycline concentrations, expressed in mg/l and standard errors 
calculated from all data collected for three biological replicates
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interesting of these is the inhibition of mitochondrial bio-
genesis [45]. Indeed, doxycycline targets mitochondria 
due to the bacterial origins of this intracellular organelle. 
It has also been shown that many ABC transport proteins 
are expressed on mitochondria [46]. Therefore, doxycy-
cline induced up- or downregulation of gene expression 
may indeed be due to mechanisms that are independent 
of its antibiotic function.
The greatest limitation to the present study is the small 
number of worm samples analyzed due to working exclu-
sively with naturally-infected dogs. First, while surgi-
cal removal of adult parasites is an increasingly popular 
option for treatment of dogs, it is still relatively uncom-
mon. A recent study has shown that only 3% of practi-
tioners carry out this procedure [47]. Secondly, while 
experimentally-infected dogs have a predictable and sub-
stantial adult worm burden, the parasitic burden is much 
lower in naturally-infected dogs, and surgical removal 
generally yields between three to six worms per dog, 
according to the dog size. Lastly, it was necessary to iden-
tify dogs that had not undergone previous macrocyclic 
lactone and/or doxycycline treatment, from veterinary 
practices within a reasonable distance from the labora-
tory, in order to obtain live, metabolically active worms.
Conclusions
The present study is the first, to the authors’ knowl-
edge, to evaluate the expression of P-gP genes in adult D. 
immitis. We have described a sex-dependent differential 
gene expression of three D. immitis P-gps treated with 
doxycycline, ivermectin and a combination of doxycy-
cline + ivermectin and suggest that this difference may be 
due to the presence of Wolbachia. It is likely that differ-
ent exposure times and drug concentrations would give 
different results. Further study, therefore, is necessary 
to determine if modulation of cellular efflux is in part 
responsible for the adulticide effect of doxycycline/mac-
rocyclic lactone combinations in heartworm-infected 
dogs.
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